Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
last updated: 26 Jan 2026
LY038
EN
04 Dec 2022
-
Competent National Authority:Food and Drug Administration ()Tiwanon Rd., Muang DistrictNonthaburi,
11000, ThailandPhone: +66 2 590 7175,Fax: +66 2 591 8460,Email: food@fda.moph.go.th,Website: http://www.fda.moph.go.th,
-
- Organization: National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency (NSTDA) | BCH-CON-TH-244493-1Organization:National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency (NSTDA)113 Thailand Science Park, Phahonyothin Rd., Klong 1, Klong LuangPathumthani,
12120, ThailandPhone: +66 2564 6700 ext 3372,Fax: +66 2564 6703,Email: biosafety@biotec.or.th,Website: http://biotec.or.th,
-
REN-ØØØ38-3 - Mavera™ maize| Changes in quality and/or metabolite content (Protein and amino acids)
- https://food.fda.moph.go.th/bch/corn29-01 [ English ]
Maize event LY038 has been genetically modified to increase lysine level in grain for use in animal feed. Although maize line LY038 is intended for use as animal feed, the applicant was submitted for food safety assessment account for potential co-mingling of LY038 maize in the food supply. According to the existing scientific data and information available during the safety assessment, it is concluded that the maize event LY038 is as safe as its conventional counterpart.
Yes
Yes
Yes
EN
Loading...
